ClinicalTrials.gov
public full text
Public Domain
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
colorectal-cancerhead-and-neck-squamous-cell-carcinomanon-small-cell-lung-cancerpancreatic-ductal-adenocarcinomasolid-tumor
This is a phase 1 multi-center, open-label study evaluating IBI3028 Treatment in participants with locally advanced, unresectable, or metastatic solid tumors
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors#1086959
- Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation#802503
- A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)#828004
- Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors#894200
- A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors#1057498
Record · ID 1173212
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive